Lista de obras -

A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals

artículo científico publicado en 2007

Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas

artículo científico publicado en 2004

Absence of NOTCH1 gene mutations in MALT lymphomas

scientific article published on 16 December 2011

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?

artículo científico publicado en 2015

Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents

artículo científico publicado en 2020

Anaplastic lymphoma kinase in human cancer

artículo científico publicado en 2011

Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications

artículo científico publicado en 2006

Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial

scientific article published on October 2006

Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: alternative drivers in anaplastic large cell lymphoma

artículo científico

Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma.

artículo científico publicado en 2016

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

artículo científico publicado en 2013

Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods

artículo científico publicado en 2008

Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial.

scientific article published on 16 July 2012

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

artículo científico publicado en 2016

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma

artículo científico publicado en 2014

Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas

artículo científico publicado en 2006

Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma

Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.

artículo científico publicado en 2015

DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features

artículo científico publicado en 2015

Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma

artículo científico publicado en 2013

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.

artículo científico publicado en 2011

Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma

artículo científico publicado en 2008

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

artículo científico publicado en 2015

Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas.

artículo científico publicado en 2004

Gains of CCND3 gene in ocular adnexal MALT lymphomas: an integrated analysis

artículo científico publicado en 2012

Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice

artículo científico publicado en 2012

Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms

artículo científico publicado en 2010

Genetics of follicular lymphoma transformation

artículo científico publicado en 2014

Genome wide DNA-profiling of HIV-related B-cell lymphomas

artículo científico publicado en 2009

Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas.

artículo científico publicado en 2013

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

scientific article published on 29 November 2010

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

artículo científico publicado en 2010

Genomic profiles of MALT lymphomas: variability across anatomical sites

artículo científico publicado en 2011

Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations

artículo científico publicado en 2017

Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma

artículo científico publicado en 2012

Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research

artículo científico publicado en 2004

In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomas.

artículo científico publicado en 2011

Infectious agents in mucosa-associated lymphoid tissue-type lymphomas: pathogenic role and therapeutic perspectives

artículo científico publicado en 2006

Integrated profiling of diffuse large B-cell lymphoma with 7q gain

artículo científico publicado en 2011

Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma.

artículo científico publicado en 2002

Latent membrane protein 1 deletion mutants accumulate in reed-sternberg cells of human immunodeficiency virus-related Hodgkin's lymphoma.

artículo científico publicado en 2005

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Pr

artículo científico publicado en 2013

MYD88 somatic mutations in MALT lymphomas

artículo científico publicado en 2012

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

artículo científico publicado en 2012

Non-negative matrix factorization to perform unsupervised clustering of genome wide DNA profiles in mature B cell lymphoid neoplasms

scientific article published on 28 April 2010

PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma

artículo científico publicado en 2013

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

artículo científico publicado en 2012

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

artículo científico publicado en 2014

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries

artículo científico publicado en 2014

Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy

artículo científico publicado en 2015

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

artículo científico publicado en 2015

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.

artículo científico publicado en 2015

Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy

scientific article published on 20 June 2005

RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.

artículo científico publicado en 2016

Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa

artículo científico publicado en 2005

Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type

artículo científico publicado en 2020

Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma

article by Andrea Rinaldi et al published 3 March 2010 in British Journal of Haematology

Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program

artículo científico publicado en 2013

Syk expression patterns differ among B-cell lymphomas

scientific article published on 07 April 2010

The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs.

artículo científico publicado en 2015

The genetics of nodal marginal zone lymphoma

scientific article published on 22 June 2016

Lista de obras de

A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals

Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas

Absence of NOTCH1 gene mutations in MALT lymphomas

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?

Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents

Anaplastic lymphoma kinase in human cancer

Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications

Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial

Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: alternative drivers in anaplastic large cell lymphoma

Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma.

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods

Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial.

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma

Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas

Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma

Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.

DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features

Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.

Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas.

Gains of CCND3 gene in ocular adnexal MALT lymphomas: an integrated analysis

Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice

Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms

Genetics of follicular lymphoma transformation

Genome wide DNA-profiling of HIV-related B-cell lymphomas

Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas.

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

Genomic profiles of MALT lymphomas: variability across anatomical sites

Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations

Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma

Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research

In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomas.

Infectious agents in mucosa-associated lymphoid tissue-type lymphomas: pathogenic role and therapeutic perspectives

Integrated profiling of diffuse large B-cell lymphoma with 7q gain

Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma.

Latent membrane protein 1 deletion mutants accumulate in reed-sternberg cells of human immunodeficiency virus-related Hodgkin's lymphoma.

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Pr

MYD88 somatic mutations in MALT lymphomas

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

Non-negative matrix factorization to perform unsupervised clustering of genome wide DNA profiles in mature B cell lymphoid neoplasms

PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries

Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.

Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy

RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.

Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa

Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type

Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma

Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program

Syk expression patterns differ among B-cell lymphomas

The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs.

The genetics of nodal marginal zone lymphoma